Премини към основното съдържание

Изследвания и иновации

Statement by Executive Vice-President Vestager on the adoption of an antitrust decision against Teva for practices involving the disparagement of a rival medicine and the misuse of the patent system

3 weeks ago
European Commission Statement Brussels, 31 Oct 2024 Today's decision to impose an antitrust fine on Teva for disparagement and misuse of the patent system reaffirms the Commission's commitment to competition enforcement in the pharmaceutical sector.
Search={format=RSS,size=10}
Subscribe to Изследвания и иновации feed
Checked

Партньори

www.cecb.bg